The KS-Bcl-2 mRNA is detected in KS lesions and in PEL cells upon induction of the lytic cycle and is required for lytic reactivation and replication (Gelgor et al., 2015; Liang et al., 2015). The gene discussed is BCL2; the disease is Kaposi's sarcoma.